Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen
Trial · NCT01757405
Adverse events34
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 34
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Laceration | Injury, poisoning and procedural complications | Arm 1: up to 3 x 90 Micrograms/kg rFVIIa BI | 1 | 18 | 1 |
| other | Laceration | Injury, poisoning and procedural complications | Arm 2: 1 x 270 Micrograms/kg rFVIIa BI | 0 | 20 | 0 |
| other | Hepatic Enzyme Increased | Investigations | Arm 1: up to 3 x 90 Micrograms/kg rFVIIa BI | 1 | 18 | 1 |
| other | Hepatic Enzyme Increased | Investigations | Arm 2: 1 x 270 Micrograms/kg rFVIIa BI | 0 | 20 | 0 |
| other | Nasal Congestion | Respiratory, thoracic and mediastinal disorders | Arm 1: up to 3 x 90 Micrograms/kg rFVIIa BI | 1 | 18 | 1 |
| other | Nasal Congestion | Respiratory, thoracic and mediastinal disorders | Arm 2: 1 x 270 Micrograms/kg rFVIIa BI | 0 | 20 | 0 |
| other | Oropharyngeal Pain | Respiratory, thoracic and mediastinal disorders | Arm 1: up to 3 x 90 Micrograms/kg rFVIIa BI | 1 | 18 | 2 |
| other | Oropharyngeal Pain | Respiratory, thoracic and mediastinal disorders | Arm 2: 1 x 270 Micrograms/kg rFVIIa BI | 0 | 20 | 0 |
| other | Drug Hypersensitivity | Immune system disorders | Arm 1: up to 3 x 90 Micrograms/kg rFVIIa BI | 1 | 18 | 1 |
| other | Drug Hypersensitivity | Immune system disorders | Arm 2: 1 x 270 Micrograms/kg rFVIIa BI | 0 | 20 | 0 |
| other | Headache | Nervous system disorders | Arm 1: up to 3 x 90 Micrograms/kg rFVIIa BI | 1 | 18 | 1 |
| other | Headache | Nervous system disorders | Arm 2: 1 x 270 Micrograms/kg rFVIIa BI | 0 | 20 | 0 |
| other | Sinus Headache | Nervous system disorders | Arm 1: up to 3 x 90 Micrograms/kg rFVIIa BI | 1 | 18 | 1 |
| other | Sinus Headache | Nervous system disorders | Arm 2: 1 x 270 Micrograms/kg rFVIIa BI | 0 | 20 | 0 |
| other | Pyrexia | General disorders | Arm 1: up to 3 x 90 Micrograms/kg rFVIIa BI | 1 | 18 | 1 |
| other | Pyrexia | General disorders | Arm 2: 1 x 270 Micrograms/kg rFVIIa BI | 0 | 20 | 0 |
| other | Influenza | Infections and infestations | Arm 1: up to 3 x 90 Micrograms/kg rFVIIa BI | 0 | 18 | 0 |
| other | Influenza | Infections and infestations | Arm 2: 1 x 270 Micrograms/kg rFVIIa BI | 2 | 20 | 2 |
| other | Nasopharyngitis | Infections and infestations | Arm 1: up to 3 x 90 Micrograms/kg rFVIIa BI | 1 | 18 | 1 |
| other | Nasopharyngitis | Infections and infestations | Arm 2: 1 x 270 Micrograms/kg rFVIIa BI | 0 | 20 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01757405/events